Immunohistochemistry to detect hereditary nonpolyposis colorectal cancer in young patients: The 7-year Auckland experience

Diseases of the Colon and Rectum

Volumn 54, Issue 5, 2011, Pages 552-558

  Wright, Deborah M ^a   Arnold, Julie L ^b   Parry, Bryan ^a,b   Hulme Moir, Michael ^c   Winship, Ingrid M ^d   Parry, Susan ^b,e  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c NORTH SHORE HOSPITAL   (New Zealand)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

Bethesda Guidelines; Hereditary nonpolyposis colorectal cancer; Immunohistochemistry; Lynch syndrome; Mismatch repair protein

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; NEW ZEALAND; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TUMOR LOCALIZATION; AGE; BASE MISPAIRING; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; TIME;

DNA; TUMOR MARKER;

ADOLESCENT; ADULT; AGE FACTORS; BASE PAIR MISMATCH; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79957972820     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31820e3265     Document Type: Article

References (21)

1. Ministry of Health. Cancer: New Registrations and Deaths 2007. Wellington, NZ: Ministry of Health; 2010.
2. James P, Parry S, Arnold J, Winship I. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand. N Z Med J. 2006;119:U2168.
3. Cunningham JM, Kim CY, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet. 2001;69:780-790. (Pubitemid 32868523)
4. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76:1-18.
5. Boland CR, Koi M, Chang DK, Carethers JM. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer. 2008;7:41-52.
6. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20:1043-1048. (Pubitemid 34141849)
7. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783-5788.
8. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10:293-300. (Pubitemid 352019113)
9. Järvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829-834. (Pubitemid 30243745)
10. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268. (Pubitemid 38256271)
11. Shia J, Tang LH, Vakiani E, et al. Immunohistochemistry as first-line screening for detecting colorectal cancer patientsat risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol. 2009;33:1639-1645.
12. de Jong AE, van Puijenbroek M, Hendriks Y, et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:972-980. (Pubitemid 38198898)
13. Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008;51:1750-1756.
14. Ward RL, Turner J, Williams R, et al. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol. 2005;207:377-384. (Pubitemid 43025685)
15. Jenkins MA, Dowty JG, Hopper JL, Southey MC. Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases. Int J Cancer. 2009;124:x-i.
16. Molaei M, Mansoori BK, Ghiasi S, Khatami F, Attarian H, Zali M. Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins. Int J Colorectal Dis. 2010;25:63-69.
17. Lee-Kong SA, Markowitz AJ, Glogowski E, et al. Prospective immunohistochemical analysis of primary colorectal cancers for loss of mismatch repair protein expression. Clin Colorectal Cancer. 2010;9:255-259.
18. South CD, Yearsley M, Martin E, Arnold M, Frankel W, Hampel H. Immunohistochemistry staining for the mismatch repair proteins in the clinical care of patients with colorectal cancer. Genet Med. 2009;11:812-817.
19. Loughrey MB, Waring PM, Tan A, et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer. 2007;6:301-310. (Pubitemid 47175009)
20. Schofield L, Watson N, Grieu F, et al. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Int J Cancer. 2009;124:1097-1102.
21. Piñol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986-1994. (Pubitemid 40570892)